The signing of a new contract with a large health system is a positive development for Streamline Health Solutions, indicating potential revenue growth and increased market penetration. This news is likely to be viewed favorably by investors, as it demonstrates the company's ability to attract significant clients and suggests confidence in its RevID technology. The impact on the stock price should be positive in the short term, reflecting the potential for enhanced financial performance and growth prospects.